Comparison between Revascularization and Optimal Medical Therapy in Patients with Stable Angina Pectoris

comparison between revascularization and optimal medical therapy in patients with stable angina pectoris

background and purpose: regarding usefulness of revascularization versus optimal medical therapy in patients with stable angina pectoris, data are challenging. the aim of this 12-month follow-up study was to compare the survival benefit associated with revascularization versus optimal medical therapy on the patients with stable angina pectoris. materials and methods: a prospective clinical stud...

Percutaneous coronary intervention with optimal medical therapy vs. optimal medical therapy alone for patients with stable angina pectoris

SCIENTIFIC BACKGROUND Stable Angina Pectoris (AP) is a main syndrome of chronic coronary artery disease (CAD), a disease with enormous epidemiological and health economic relevance. Medical therapy and percutaneous coronary interventions (PCI) are the most important methods used in the treatment of chronic CAD. RESEARCH QUESTIONS The evaluation addresses questions on medical efficacy, increme...

Therapy of Stable Angina Pectoris

Case study: A 62-year-old male smoker with type 2 diabetes mellitus and hypertension presents with a 4-month history of exertional chest pain. Physical examination shows a blood pressure of 152/90 mm Hg but is otherwise unremarkable. The ECG is normal, and laboratory tests show a fasting blood glucose value of 110 mg/dL, glycosylated hemoglobin 6.0%, creatinine 1.1 mg/dL, total cholesterol 160,...

Anticardiolipin and Antiphospholipid Antibodies in Iraqi Patients with Angina Pectoris

Editorial Comment Medical Therapy of Chronic Stable Angina Pectoris

O ur understanding of chronic stable angina is gradually expanding, and two theories have developed in recent years. First, in patients with chronic stable angina, residual coronary flow reserve can be modulated to an important extent by dynamic changes in the caliber of pliable coronary artery stenoses with preserved muscular media.' This theory, coupled with the evidence of the remarkable eff...

Medical management of stable angina pectoris.

The number of drugs available for treatment of angina pectoris has increased dramatically in recent years; new beta and calcium channel blockers are to be introduced; nitrates are now available in transdermal pads and could become released as buccal tablets or aerosol sprays. A broad understanding of the pharmacological principles of their use is necessary to tailor therapy for each patient.